Facebook
Twitter
LinkedIn
ForwardMiami Cancer Institute Summit of the Americas on Immunotherapies for Hematologic Malignancies, Third Annual
Given the increasing frequency of hematologic malignancies, complexities of treatments with novel agents and particularly with immunotherapeutic approaches, there is a need to provide an opportunity for oncologists, hematologists, oncology nurses and pharmacists to engage in thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders. Clinical decision making and management therefore have become more complex.
This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of leukemia, lymphoma, multiple myeloma and stem cell transplantation by novel immunotherapies and treatment combinations. Updates on evolving immunologically and molecular based system therapies will be profiled and discussed.
Agenda - Friday, April 8, 2022
| 7:30 - 8:30 a.m. | Registration and Continental Breakfast |
| 8:30 - 8:45 a.m. | Welcome and Introductions Guenther Koehne, M.D., Ph.D. |
| Acute Myeloid Leukemia | |
| 8:45 - 9:15 a.m. | Treatment Approach for High-risk Acute Myeloid Leukemia in 2022 Richard Stone, M.D. |
| 9:15 - 9:45 a.m. | Overcoming Resistance to Targeted Therapies in Acute Myeloid Leukemia Eytan Stein, M.D. |
| 9:45 - 10:15 a.m. | Myelofibrosis: Current and Emerging Treatments Raajit Rampal, M.D. |
| 10:15 - 10:45 a.m. | Break and Exhibits |
| Acute Lymphoid Leukemia | |
| 10:45 - 11:15 a.m. | Updates on Treatment Approaches for Acute Lymphoblastic Leukemia Hagop Kantarjian, M.D. |
| 11:15 - 11:45 a.m. | Improving Outcomes in T-ALL: Challenges and New Directions Wendy Stock, M.D. |
| 11:45 a.m. - 12:15 p.m. | Lunch and Exhibits |
| 12:15 p.m. - 12:45 p.m. | Product Theater – Pfizer |
| Multiple Myeloma | |
| 1:15 - 1:45 p.m. | Treatment Approaches for Multiple Myeloma in 2022 Paul Richardson, M.D. |
| 1:45 - 2:15 p.m. | Update on BCMA-Directed Therapies for Multiple Myeloma Adam Cohen, M.D. |
| 2:15 - 2:45 p.m. | Wilms’ Tumor Antigen 1 in Multiple Myeloma Guenther Koehne, M.D., Ph.D. |
| 2:45 - 3:15 p.m. | Signature Human B-Cell Surface Glycosylation Can Provide Key Insights for Treating B-Cell Malignancies Charles Dimitroff, Ph.D. |
| 3:15 - 3:30 p.m. | Break and Exhibits |
| Non-Hodgkin Lymphoma | |
| 3:30 - 4:00 p.m. | Updates on Treatment Approaches in Diffuse Large B-Cell Lymphoma (DLBCL) Matthew Matasar, M.D. |
| 4:00 - 4:30 p.m. | Updates on Treatment Approaches for Primary (CNS) Lymphoma Craig Sauter, M.D. |
| 4:30 - 5:00 p.m. | Questions and Answers |
| 5:00 p.m. | Adjourn |
Agenda - Saturday, April 9, 2022
| 7:30 - 8:00 a.m. | Product Theater – Bristol-Myers Squibb |
| 8:00 - 8:30 a.m. | Registration and Continental Breakfast |
| Allogeneic Stem Cell Transplants | |
| 8:30 - 9:00 a.m. | The Role of Intestinal Microbiome in Hematopoietic Stem Cell Transplantation and Immuno-oncology Marcel van den Brink, M.D., Ph.D. |
| 9:00 - 9:30 a.m. | The Impact of CAR T-Cell Therapy on Hematopoietic Stem Cell Transplantation Robert Soiffer, M.D. |
| CAR Cell Therapies | |
| 9:30 - 10:15 a.m. | Keynote Address - Next Steps in CAR T-cell Therapies Michel Sadelain, M.D., Ph.D. |
| 10:15 - 10:45 a.m. | Break and Exhibits |
| 10:45 - 11:15 a.m. | Product Theater – Janssen |
| 11:15 - 11:45 a.m. | Lunch and Exhibits |
| 11:45 a.m. - 12:15 p.m. | Optimizing CAR Cell-based Immunotherapy by Targeting the Cancer Cell “Sugar-Coat” Robert Sackstein M.D., Ph.D. |
| 12:15 - 12:45 p.m. | Novel Approaches of CAR T-cell Therapies for AML Siddhartha Mukherjee, M.D. |
| 12:45 p.m. - 1:15 p.m. | Do CARs Always Have to Be T-Cells Paul Lin, M.D. |
| 1:15 - 1:45 p.m. | Questions and Answers |
| 1:45 p.m. | Adjourn |
NOTE: Schedule subject to change.
About the Venue
Miami might stimulate the mind for glitter and glamour, but it is the city’s Coconut Grove district that serves up its cultural soul. Art galleries, museums, boutiques and restaurants beckon visitors to this historic Florida neighborhood, along with The Ritz-Carlton Coconut Grove, Miami, a hotel destined to enchant every guest with a truly unique hospitality experience. Inspired by the peacock hues of blue, violet and green, the hotel exquisitely blends in to the lush surroundings of this Biscayne Bay artist enclave, making it a work of art itself. Enjoy dining that exemplifies Miami’s diverse mix of cultural flavors. Find inner tranquility with a customized spa experience. Or let the glow of a fire pit and the comfort of an oversized couch make an evening on our Courtyard Fountain Terrace all the more memorable. The Ritz-Carlton Coconut Grove, Miami is also just minutes from first-class shopping and dining in Brickell, Miami.
Symposium Director
 | Guenther Koehne M.D., Ph.D. Deputy Director of Miami Cancer Institute Chief of Blood & Marrow Transplant and Hematologic Oncology Miami Cancer Institute Miami, Florida |
Faculty
 | Adam D. Cohen, M.D. Assistant Professor of Medicine Abramson Cancer Center University of Pennsylvania Philadelphia, Pennsylvania |
 | Charles J. Dimitroff, Ph.D. Director, Translational Glycobiology Institute at FIU Professor, Department of Translational Medicine Herbert Wertheim College of Medicine Florida International University |
 | Hagop Kantarjian, M.D. Department of Leukemia Division of Cancer Medicine MD Anderson Cancer Center |
 | Paul Lin M.D., Ph.D. Instructor at The University of Texas MD Anderson Cancer Center Houston, Texas |
 | Matthew J. Matasar, M.D. Section Lead, Aggressive B-cell Lymphoma Associate Member, Lymphoma Service Memorial Sloan Kettering Cancer Center New York, New York |
 | Siddhartha Mukherjee, M.D. Medical Oncologist Columbia University Herbert Irving Comprehensive Cancer Center |
 | Raajit K. Rampal, M.D., Ph.D. Associate Member Clinical Director Leukemia Service Memorial Sloan Kettering Cancer Center New York, New York |
 | Paul G. Richardson, M.D. Clinical Program Leader and Director of Clinical Research Jerome Lipper Multiple Myeloma Center Dana-Farber Cancer Institute RJ Corman Professor of Medicine Harvard Medical School Boston, Massachusetts |
 | Robert Sackstein, M.D. Senior Vice President for Health Affairs Dean, Herbert Wertheim College of Medicine Florida International University Miami, Florida |
 | Michel Sadelein, M.D. Director Center for Cell Engineering Memorial Sloan Kettering New York, New York |
 | Craig Sauter, M.D. Hematologic Oncologist Clinical Director Adult Bone Marrow Transplant Service Memorial Sloan Kettering |
 | Robert Soiffer, M.D. Chief, Division of Hematologic Malignancies Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School Boston, Massachusetts |
 | Eytan M. Stein, M.D. Assistant Attending Physician Director, Program for Drug Development in Leukemia Leukemia Service, Department of Medicine Memorial Sloan Kettering Cancer Center New York, New York |
 | Wendy Stock, M.D. Hematologist/ Oncologist Professor of Medicine University of Chicago Chicago, Illinois |
 | Richard M. Stone, M.D. Chief of Staff, Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School Boston, Massachusetts |
 | Marcel R. van den Brink, M.D. Medical Oncologist Head, Division of Hematologic Malignancies Memorial Sloan Kettering |
Accreditation
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baptist Health South Florida designates this live activity for a maximum of 9.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 9.75 credit hours by the Florida Boards of Medicine and Osteopathic Medicine and by the Florida Council of Physician Assistants, CE Broker Provider #50-182. 6 credits for the Friday session (CE Broker #20-904413) and 3.75 credits for the Saturday session (CE Broker #20-904417).
This activity has been approved for a total of 9.5 contact hours by the Florida State Boards of Nursing and Laboratory Personnel, and approved for 9.75 contact hours for Pharmacy. CE Broker Provider #50-182.
The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Disclaimer
Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.
While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.
We gratefully recognize these supporters:
Platinum Supporters
Bristol-Myers Squibb
Janssen Pharmaceuticals
Pfizer Pharmaceuticals
Price
| ⚠ | COVID-19 Protocols Notice for All Attendees, Exhibitors and VendorsSelf-screening is required for all in-person attendees. If you have any symptoms of respiratory illness, you must refrain from attending in person. Please be sure to read our COVID Protocols for all in-person education prior to registering for this activity. |